Artificial Intelligence and Cancer Clinical Research: III Risk Prediction Models for Febrile Neutropenia in Patients Receiving Cancer Chemotherapy.
Publication
, Journal Article
Lyman, GH; Kuderer, NM
Published in: Cancer Invest
August 2024
Duke Scholars
Published In
Cancer Invest
DOI
EISSN
1532-4192
Publication Date
August 2024
Volume
42
Issue
7
Start / End Page
539 / 543
Location
England
Related Subject Headings
- Risk Factors
- Risk Assessment
- Oncology & Carcinogenesis
- Neoplasms
- Humans
- Febrile Neutropenia
- Artificial Intelligence
- Antineoplastic Agents
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H., & Kuderer, N. M. (2024). Artificial Intelligence and Cancer Clinical Research: III Risk Prediction Models for Febrile Neutropenia in Patients Receiving Cancer Chemotherapy. Cancer Invest, 42(7), 539–543. https://doi.org/10.1080/07357907.2024.2370692
Lyman, Gary H., and Nicole M. Kuderer. “Artificial Intelligence and Cancer Clinical Research: III Risk Prediction Models for Febrile Neutropenia in Patients Receiving Cancer Chemotherapy.” Cancer Invest 42, no. 7 (August 2024): 539–43. https://doi.org/10.1080/07357907.2024.2370692.
Lyman GH, Kuderer NM. Artificial Intelligence and Cancer Clinical Research: III Risk Prediction Models for Febrile Neutropenia in Patients Receiving Cancer Chemotherapy. Cancer Invest. 2024 Aug;42(7):539–43.
Lyman, Gary H., and Nicole M. Kuderer. “Artificial Intelligence and Cancer Clinical Research: III Risk Prediction Models for Febrile Neutropenia in Patients Receiving Cancer Chemotherapy.” Cancer Invest, vol. 42, no. 7, Aug. 2024, pp. 539–43. Pubmed, doi:10.1080/07357907.2024.2370692.
Lyman GH, Kuderer NM. Artificial Intelligence and Cancer Clinical Research: III Risk Prediction Models for Febrile Neutropenia in Patients Receiving Cancer Chemotherapy. Cancer Invest. 2024 Aug;42(7):539–543.
Published In
Cancer Invest
DOI
EISSN
1532-4192
Publication Date
August 2024
Volume
42
Issue
7
Start / End Page
539 / 543
Location
England
Related Subject Headings
- Risk Factors
- Risk Assessment
- Oncology & Carcinogenesis
- Neoplasms
- Humans
- Febrile Neutropenia
- Artificial Intelligence
- Antineoplastic Agents
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis